AJ1-10502

N/A

Report date: 2025/01/26 18:09:31
NME

Base Information

Drug NameAJ1-10502
Drug Alias NameType II JAK2 inhibitors (Ajax Therapeutics/Schrodinger)AJ1-10502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsMyeloproliferative Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAjax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAjax Therapeutics IncSchrodinger Inc
Inactive CompaniesN/A
Active IndicationsMyeloproliferative Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A